Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-11

Clinical Trial Update: Recombinant Human Serum Albumin in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating recombinant human serum albumin in healthy subjects, sponsored by Protgen Ltd. Hepatic Ascites is listed as the condition stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Recombinant Human Serum Albumin (recombinant human serum albumin)

Snippet

Sponsor: Protgen Ltd | Conditions: Hepatic Ascites | Phase 1 | Status: COMPLETED